{"id":"W2719623628","doi":"10.1634/theoncologist.2017-0072","title":"Palbociclib Combined with Fulvestrant in Premenopausal Women with Advanced Breast Cancer and Prior Progression on Endocrine Therapy: PALOMA-3 Results","year":2017,"lang":"en","type":"article","venue":"The Oncologist","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":158,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Calgary","funders":"Cancer Research UK; AstraZeneca; American Society of Clinical Oncology; Pfizer","keywords":"Palbociclib; Fulvestrant; Medicine; Goserelin; Anastrozole; Internal medicine; Oncology; Breast cancer; Adverse effect; Neutropenia; Placebo; Letrozole; Gynecology; Cancer; Metastatic breast cancer; Chemotherapy; Tamoxifen","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002995182,0.0003219509,0.0004976324,0.00005313869,0.0003886244,0.00006266612,0.0002871,0.0000608854,0.00002835875],"category_scores_gemma":[0.00003776151,0.0001531973,0.00001638395,0.0001068331,0.000988199,0.000180777,0.00007025772,0.0003768025,0.000002523155],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003448621,"about_ca_system_score_gemma":0.0002447782,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00018743,"about_ca_topic_score_gemma":0.0007256797,"domain_scores_codex":[0.9982732,0.00006838008,0.0002704791,0.0004886982,0.0003599646,0.0005393102],"domain_scores_gemma":[0.9984123,0.0001112568,0.0003822666,0.0008507885,0.00009553602,0.0001478903],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.2487009,0.0007418265,0.0403353,0.00007491041,0.0001767207,0.0003994837,0.002023934,0.00009134987,0.007364981,0.0001081168,0.0000224937,0.69996],"study_design_scores_gemma":[0.03727097,0.01476186,0.9398801,0.0009472894,0.00003616068,0.0002935355,0.0007724527,0.00002247919,0.002495643,0.0001502883,0.003081044,0.0002881226],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9813605,0.0003978201,0.000005208969,0.01516129,0.00006601561,0.001648497,0.00005621009,0.00008880354,0.001215668],"genre_scores_gemma":[0.9970024,0.0005228762,0.0007079193,0.0004145923,0.0001241536,0.0007225432,0.000007627903,0.00004899911,0.0004488642],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.8995448,"threshold_uncertainty_score":0.6247206,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02206593019534308,"score_gpt":0.3371386426214998,"score_spread":0.3150727124261567,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}